Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Should Value Investors Buy Cenovus Energy (CVE) Stock?
Should Value Investors Buy Cenovus Energy (CVE) Stock?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Is Alkermes (ALKS) Stock Outpacing Its Medical Peers This Year?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Is Alkermes (ALKS) Stock Outpacing Its Medical Peers This Year?

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Alkermes (ALKS) been one of those stocks this year? By

Is Roku (ROKU) Stock Outpacing Its Consumer Discretionary Peers This Year?
Is Roku (ROKU) Stock Outpacing Its Consumer Discretionary Peers This Year?

Investors interested in Consumer Discretionary stocks should always be looking to find the best-performing companies in the group. Is Roku (ROKU) one of those stocks right now? By taking a look at

Here's Why Eversource Energy (ES) is a Strong Value Stock
Here's Why Eversource Energy (ES) is a Strong Value Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Should Value Investors Buy InfuSystems Holdings (INFU) Stock?
Should Value Investors Buy InfuSystems Holdings (INFU) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Kimball Electronics Q1 Earnings and Revenues Surpass Expectations
Kimball Electronics Q1 Earnings and Revenues Surpass Expectations

Kimball Electronics, Inc. KE reported first-quarter fiscal 2026 non-GAAP earnings of 49 cents per share, which beat the Zacks Consensus Estimate by 104.2%. The company reported earnings of 22 cents

American Financial Q3 Earnings Beat on Higher Underwriting Show
American Financial Q3 Earnings Beat on Higher Underwriting Show

Shares of American Financial Group, Inc. AFG gained 2.8% in the last trading session as the company reported better-than-expected earnings for the third quarter of 2025. The company reported

After Plunging 18.6% in 4 Weeks, Here's Why the Trend Might Reverse for Grocery Outlet (GO)
After Plunging 18.6% in 4 Weeks, Here's Why the Trend Might Reverse for Grocery Outlet (GO)

A downtrend has been apparent in Grocery Outlet Holding Corp. (GO) lately with too much selling pressure. The stock has declined 18.6% over the past four weeks. However, given the fact that it is

Down 13.4% in 4 Weeks, Here's Why Perdoceo Education (PRDO) Looks Ripe for a Turnaround
Down 13.4% in 4 Weeks, Here's Why Perdoceo Education (PRDO) Looks Ripe for a Turnaround

Perdoceo Education (PRDO) has been beaten down lately with too much selling pressure. While the stock has lost 13.4% over the past four weeks, there is light at the end of the tunnel as it is now in

After Plunging 22.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid7 (RPD)
After Plunging 22.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid7 (RPD)

Rapid7 (RPD) has been on a downward spiral lately with significant selling pressure. After declining 22.7% over the past four weeks, the stock looks well positioned for a trend reversal as it is now

After Plunging 12.7% in 4 Weeks, Here's Why the Trend Might Reverse for TriMas (TRS)
After Plunging 12.7% in 4 Weeks, Here's Why the Trend Might Reverse for TriMas (TRS)

TriMas (TRS) has been beaten down lately with too much selling pressure. While the stock has lost 12.7% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

Down 10.4% in 4 Weeks, Here's Why Grifols (GRFS) Looks Ripe for a Turnaround
Down 10.4% in 4 Weeks, Here's Why Grifols (GRFS) Looks Ripe for a Turnaround

Grifols (GRFS) has been beaten down lately with too much selling pressure. While the stock has lost 10.4% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

Antero Resources Stock Gains 4% Despite Q3 Earnings MissPhoto, wide shot, wide-angle lens,  Coal company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.midjourneyapi.xyz/temp/2a011bdc-adca-4de9-8457-d868b31178cf.png
Antero Resources Stock Gains 4% Despite Q3 Earnings Miss

Antero Resources Corporation AR rose 3.8% despite reporting lower-than-expected earnings on Oct. 29. This signifies rising natural gas demand backed by power-hungry data centers and increasing LNG

Lightspeed POS (LSPD) Reports Q2 Earnings: What Key Metrics Have to Say
Lightspeed POS (LSPD) Reports Q2 Earnings: What Key Metrics Have to Say

Lightspeed Commerce Inc. (LSPD) reported $318.96 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 15.1%. EPS of $0.16 for the same period compares

MSG Entertainment (MSGE) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
MSG Entertainment (MSGE) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Madison Square Garden Entertainment (MSGE) reported revenue of $158.26 million, up 14.1% over the same period last year. EPS came in at -$0.46, compared to

Somnigroup International (SGI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Somnigroup International (SGI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Somnigroup International (SGI) reported revenue of $2.12 billion, up 63.3% over the same period last year. EPS came in at $0.95, compared to $0.82 in the

Compared to Estimates, P10 (PX) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, P10 (PX) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, P10, Inc. (PX) reported revenue of $75.93 million, up 2.3% over the same period last year. EPS came in at $0.24, compared to $0.26 in the year-ago quarter.

The

Becton Dickinson (BDX) Reports Q4 Earnings: What Key Metrics Have to Say
Becton Dickinson (BDX) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Becton Dickinson (BDX) reported revenue of $5.89 billion, up 8.3% over the same period last year. EPS came in at $3.96, compared to $3.81 in the year-ago

Haemonetics (HAE) Reports Q2 Earnings: What Key Metrics Have to Say
Haemonetics (HAE) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Haemonetics (HAE) reported revenue of $327.32 million, down 5.3% over the same period last year. EPS came in at $1.27, compared to $1.12 in the year-ago

Olaplex (OLPX) Reports Q3 Earnings: What Key Metrics Have to Say
Olaplex (OLPX) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Olaplex Holdings, Inc. (OLPX) reported revenue of $114.58 million, down 3.8% over the same period last year. EPS came in at $0.02, compared to $0.04 in the

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 EarningsPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings

Collegium Pharmaceutical (COLL) reported $209.36 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 31.4%. EPS of $2.25 for the same period compares

Warner Bros. Discovery (WBD) Reports Q3 Earnings: What Key Metrics Have to Say
Warner Bros. Discovery (WBD) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Warner Bros. Discovery (WBD) reported revenue of $9.05 billion, down 6% over the same period last year. EPS came in at -$0.06, compared to $0.05 in the year-ago

Compared to Estimates, Hyatt Hotels (H) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Hyatt Hotels (H) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, Hyatt Hotels (H) reported revenue of $1.79 billion, up 9.6% over the same period last year. EPS came in at -$0.30, compared to $0.94 in the year-ago quarter.

Here's What Key Metrics Tell Us About Air Products and Chemicals (APD) Q4 Earnings
Here's What Key Metrics Tell Us About Air Products and Chemicals (APD) Q4 Earnings

For the quarter ended September 2025, Air Products and Chemicals (APD) reported revenue of $3.17 billion, down 0.7% over the same period last year. EPS came in at $3.39, compared to $3.56 in the